Introduction
yclosporine A (CsA), a natural polypeptide with potent immunosuppressive activity, was derived from extracts of Topocladium inflatum gams, a member of the Fungi imperfecti family (Kahan, 1999) . CsA is commonly used as anti-rejection drug for organ transplantation and for treatment of some autoimmune diseases (Ponticelli, 2005) .
Several toxic effects have been reported in both transplant and nontransplant settings (autoimmune disorders), including nephrotoxicity, hepatotoxicity, C neurotoxicity, hypertension, dyslipidemia, gingival hyperplasia, hypertrichosis, malignancies and increased risk of cardiovascular toxicity (Olyaei et al., 2001) .
Although mechanisms by which CsA-induced toxicity are still not clear, the former clinical and experimental findings have suggested that formation of free oxygen radicals, lipid peroxidation, and induction of cytochrome P-450 system and oxidative stress is a possible pathway of CsA-induced toxicity (Sanchez et al, 2001 and Bianchi et al, 2003) .
Oxidative stress is defined as a tissue injury due to imbalance between the production of oxidants and endogenous antioxidant defense systems of an organism. Oxidants include reactive oxygen species (ROS), reactive nitrogen species, sulpher-centered radicals and others. The important cellular sources of oxidative stresses are respiratory chain of mitochondria and the oxidative burst mediated by NADPH oxidase and Nitric Oxide (NO) (Abuja and Albertini, 2001 ). On the other hand super oxide dismutase, catalase, glutathione peroxidase and cytochrome-c oxidase are endogenous antioxidants which play a role in the prevention of oxidative injury (Akyol et al, 2002) .
Coenzyme Q10 (CoQ 10 ) is a fat soluble, vitamin-like benzoquinone compound that functions primarily as an endogenous antioxidant, membrane stabilizer, and a cofactor in the oxidative phosphorylation processes. The rational for the use of CoQ 10 as a medical agent for treating cardiovascular diseases is based on its fundamental role in mitochondrial function and cellular bioenergetics (Ochiai et al, 2007) .
The level of CoQ 10 is reduced with increasing age and under the conditions of illness, for example after renal transplantation (Beyer, 1990) .
Since, the myocardial protection during the CsA treatment should be remained the goal to enhance the beneficial effects of the drug as well as to remove the risk of cardiac problems, the present study was done aiming to detect the possible morphological and structural changes that may occur in the cardiac muscle of the adult male albino rats due to CsA therapy and to test the effect of CoQ 10 against CsA-induced cardiotoxicity.
Materials and methods
Thirty adult male albino rats, of local strain, weighing 180-200 mg were used in this study. Female rats were excluded from the study to avoid the hormonal fluctuation during the menstrual cycle, which may influence the drug metabolism. They were housed in stainless steel cages and maintained at room temperature with a 12 hour light-dark cycle and received a standard food and water ad libitum. They were randomly classified into 3 groups (10 rats each):
− Group (I) (Control group): that was further subdivided into 2 equal subgroups, each of 5 animals: subgroup 1a: received olive oil (vehicle of CoQ 10 and CsA), 1 ml/kg orally for 28 days. Subgroup 1b: (CoQ 10 group): received 5 mg/kg/day of CoQ 10 orally for 28 days (Crane, 2008) . − Group (II) (CsA-treated group):
The rats received 25 mg/kg/day CsA orally for 28 days (Ebru et al, 2008 Systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR) were recorded three times per week by the noninvasive method of tail-cuff plethymography (Indirect Blood Pressure Controller) in conscious rats. All procedures were performed around 1:00 p.m. to avoid any potential circadian influences (Rezzani et al, 2006) .
At the time of sacrifice, all the animals were anesthetized by ether inhalation. Their hearts were carefully dissected out and their left ventricles were taken and a longitudinal cut was performed and half of each ventricle was processed for light microscopic study and the other for electron microscope. Specimens for light microscopic examination were fixed in 10% neutral formal saline for 24 hours and were processed to prepare 5µm thick paraffin sections for Haematoxylin and Eosin (H&E) and Mallory's trichrome (Bancroft and Gamble, 2002) . For electron microscope study; small myocardial biopsies (1 mm³) were taken, fixed in 2% glutaraldehyde and post fixed in 1% osmium tetroxide, dehydrated and embedded in epoxy resin. One µm sections (semithin sections) were preliminary obtained and stained with toluidine blue (Kiernan, 2000) . Ultrathin sections were cut and double stained with uranyle acetate and lead citrate and examined by JEOL JEM 1010 transmission electron microscope in Electron Microscope Research Laboratory (EMRL), Histology Department, Faculty of Medicine, Zagazig University (Glauret and Lewis, 1998) .
Statistical analysis
The obtained data of SBP, DBP and HR of all groups were subjected to one-way ANOVA. The mean difference was considered significant at p<0.05.
Results

Blood pressure and heart rate results
Oral administration of CsA, produced a significant (p<0.05) elevation in SBP, DBP, and HR in comparison with the control group. Treatment with CoQ 10 significantly (p<0.05) reduced the increments in SBP, DBP and HR in comparison with CsA-treated rat group. However, the recorded values were still significantly (p<0.05) higher than that of the control group, Table (1) and Chart (1).
Histological Results
I--Light microscopic results
A--Haematoxylin and Eosin stain
Examination of H&E stained sections of the control group (subgroup 1a and 1b) revealed the classical architecture of the cardiac muscle fibers. They appeared arranged in a linear array that branch and anastomose giving the appearance of a sheet. They contained acidophilic sarcoplasm with oval, single, centrally located nuclei (Fig.1) .
H&E stained myocardial sections of CsAtreated rats (group II) revealed apparent disorganization of the muscle fibers. They exhibited areas of myofibrillar degeneration accompanied with small deeply stained nuclei. Moreover, interstitial cellular infiltration was recognized (Fig.2) . These changes were also associated with presence of extravasated red blood cells among muscle cells as well as wide interstitial spaces were revealed ( Fig.3) Co-administration of CoQ10 and CsA showed that most of the muscle fibers exhibited nearly normal appearance. However, most of their nuclei were centrally located but darkly stained. In addition, few sarcoplasmic vacuoles were still persistent (Fig.4) .
B--Mallory's trichrome stain
The cardiac muscle of the control group (subgroup1a &1b) revealed delicate collagen fibers in the endomysium (Fig.5 ). On the other hand, sections of CsA-treated rat (group II) exhibited increase deposition of collagen fibers in the interstitial spaces (Fig.6) . Whereas, upon combination of CoQ10 and CsA, fine and delicate collagen fibers deposition among cardiac myocytes was noticed (Fig.7) .
C--Toluidine blue stain
Examination of semithin sections of cardiac muscle fibers of control rats (subgroup1a &1b) revealed polygonal appearance of the muscle cells with centrally located nuclei and darkly stained mitochondria were appeared. Normal blood capillaries were found in the endomysium (Fig.8) . However, semithin sections in myocardium of CsA-treated rat (group II) depicted sarcoplasmic vacuoles and peripherally located nuclei. In addition, interstitial blood vessels were congested (Fig.9) . While, simultaneous administration of CoQ10 and CsA revealed that most of cardiac myocytes retained nearly normal appearance with centrally located nuclei and dark stained mitochondria (Fig.10) .
II--Electron microscopic results
Electron microscopic examination of cardiac muscle fibers of control rats (subgroup1a &1b) revealed its normal ultrastructure. Cardiac myocytes exhibited single central oval euchromatic nuclei with prominent nucleoli. Their sarcoplasm appeared packed with longitudinally arranged myofibrils showing its cross banding pattern that oriented into sarcomeres. Numerous mitochondria were arranged in rows between the myofibrils. Cardiac myocytes attached end to end by intercalated discs. Each disc consisted of a stepwise arrangement of longitudinal and transverse components. The longitudinal (lateral) portion was parallel to the myofibrils while the transverse portion was localized at the level of Z-line (Fig.11) .
Examination of the myocardium of CsAtreated rats (group II) revealed obvious ultrastructural disturbances. Most of the cardiac myocytes showed loss of normal pattern of the myofibrils with shorting of sarcomeres. As well as some myofibrillar fragmentation and sarcoplasmic vacuolation were apparent. Disorganized mitochondria were also observed and were displayed in groups. Most of nuclei appeared electron dense with condensation of clumps of heterochromatin. In addition disruption of intercalated discs were depicted (Fig.12) . These changes were associated with inflammatory cellular infiltration and increase deposition of collagen fibers in the interstitial spaces (Figs. 13&14) .
Co-administration of CoQ 10 and CsA reflected a considerable degree of decreased myocardial changes of CsA insults. As most of the cardiac myocytes showed regular pattern of striation with well organized sarcomeres, relatively regular arranged mitochondria and regular pattern of intercalated discs. Euchromatic nuclei were also obvious. However, some cardiac muscle cells still exhibited interruption and fragmentation of myofibrils as well as bizarre shaped mitochondria (Figs. 15, 16 &17). 
n). Its sarcoplasm is packed with longitudinally arranged myofibrils that are oriented into sarcomeres (s). Mitochondria are arranged in rows between the myofibrils (m). Intercalated disc is found between cardiac myocytes with its transverse portion (arrow) at Z-line (curved arrow) and its lateral (longitudinal) portion parallel to the myofibrils (arrow head). (X4000)
Discussion
Cyclosporin-A (CsA) is the most frequently used immune-suppressant in transplant surgery and in the treatment of autoimmune diseases. It has been shown that CsA is able to generate reactive oxygen species and lipid peroxidation, which are directly involved in the CsA-induced cardiotoxicity. The cardiovascular complication remains the main cause of post transplantation mortality (Reis et al, 2007) . So, the aim of this work was to study the blood pressure and heart rate changes as well as the histopathological changes in the cardiac muscles after administration of CsA in adult male albino rats for 28 days. We aimed also to study the efficacy of CoQ 10 as a protector against CsAinduced cardiotoxicity.
In the present work, administration of CsA in a dose of 25mg/kg/day for 28 days induced significant elevation in SBP, DBP, and HR in comparison with the control group. These findings are consistent with Oriji and Schanz, 2001 , who reported that CsA increases the mean arterial pressure in normotensive rats.
CsA induced hypertension could be attributed to several mechanisms: Activation of rennin angiotensin system, enhancement of α -1 adrenoceptor affinity to noradrenalin and their related transduction mechanisms including increase in calcium influx and inositol phosphate turn over, and activation of protein kinase (Oriji and Schanz, 2001) .
Throughout the present study, CsA induced apparent increase in the heart rate that was in accordance with the report of Omar and El-Mas, 2004 , who attributed this effect to the attenuation of vagal activity and enhancement of sympathetic activity by CsA. Furthermore, Florio et al, 2003 , reported that CsA increases calcium influx (Ca ++ overload) and enhances lipid peroxidation in cardiomyocytes leading to cardiotoxicity. In the present work, administration of CoQ 10 in a dose of 5mg/kg/day along with CsA produced significant decrease in the CsA-induced elevation in arterial blood pressure and heart rate as compared to the rats received CsA alone. However, the recorded values were still significantly higher than that of the control group. Tran et al, 2001 , reviewed eight different trials that documented the decrease in blood pressure following different doses of CoQ 10 .
Systemic reviews and meta-analysis have been conducted evaluating CoQ 10 in hypertension versus placebo. Decrease in SBP was found in some patients. However, confounding variables, small trial size, and variable study designs make extrapolation of the data difficult (Pepe et al, 2007) . Rezzani et al, 2006 , showed comparable results when using melatonin as a cardio protective agent against CsA-induced hypertension.
Histological results of the current work clearly demonstrated that CsA administration induced prominent myocardial changes in the form of disorganization of the muscle fibers with areas of myofibrillar degeneration accompanied with small deeply stained, peripherally located nuclei. Intense cellular infiltration and areas of increased collagen fibers deposition were revealed as well. Ultrastructurally, apparent changes involving the myofibrils, mitochondria, intercalated discs and nuclei were encountered. These results were in agreement with Bianchi et al, 2003; Rezzani, 2004 and Selcoki et al, 2007 . The results of the previous researches indicate that myocardial changes involved both the atria and ventricles in CsA treated rats.
In the present study, myofibrillar affections included shortened sarcomeres, myofibrillar fragmentations and sarcoplasmic vacuolations. This change could be attributed to Ca ++ overload that enhances the contractile forces within the muscle (Florio et al, 2003) . The previous researchers demonstrated an evident increase in intracellular Ca ++ in rat cardiomyocytes in a dose-dependent manner following CsA-treatment. They suggested that CsA toxicity might be attributed to Ca ++ overload that in turn, induced lipid peroxidation and consequent cell injury. Mitochondria were among the affected organelles. They were frequently seen disorganized with loss of normal orientation and present in groups. Such mitochondrial alterations could be attributed to elevated intracellular calcium accumulation and consequent lipid peroxidation of mitochondrial membranes. The effect occurs when ROS attack the double bond of unsaturated fatty acids leading to formation of peroxides that lead to propagation of extensive membrane damage. This might also explain the observed of the intercalated discs. This interpretation was supported by Molkentin (2001) who stated that CsA is one of the direct effectors of mitochondrial integrity. He added that CsA act as a potent suppressor of membrane destabilization and subsequent initiation of apoptosis.
Throughout the present study, prominent nuclear changes were in the form of dark, small, and condensation of clumps of heterochromatin (apoptotic nuclei). Cardiac myocytes of CsA-treated rats displayed peripherally located nuclei during light microscopic examination. This was explained by the fact that desmin cytoskeletal intermediate filaments form a sarcoplasmic network radiating from the sarcolemma to the nuclear surface close to the nuclear pores which is related to lamin B nucleoskeletal intermediate filaments. Disruption of this cytoskeleton by stimulation of protease enzymes secondary to disrupted calcium homeostasis due to CsA administration would be responsible for nuclear displacement of cardiac myocytes (Stacchiotti et al., 2009) .
One of the prominent changes observed in most of cardiac sections of CsA treated group were congestion, dilatation of blood vessels and extravasations of blood cells in the wide interstitium. These observations were consistent with Yüce et al, 2008 . These changes were mostly explained by increase nitric oxide (NO) production which is endothelium relaxation factor with subsequent vasodilatation. NO is a free radical molecule that plays a key role in CsA-induced myocardial injury. In support for this explanation, high NO production has been demonstrated in the myocardium during CsA therapy (Ebru et al., 2008) .
Interstitial fibrosis encountered in the CsAtreated group could be explained on the basis of the fact that ROS production activates matrix metalloproteinase enzymes and induces a decrease in their endogenous inhibitors with imbalance between matrix deposition and degradation (Siwik et al, 2001) . They reported dysregulation of the myocardial extracellular matrix in different cardiomyopaties, upregulation of metalloproteinases with inhibition of endogenous inhibitors systems. Bianchi et al, 2003 , observed that after CsA treatment, there is increase in the metalloproteinase activity and the myocardial extracellular matrix. They also reported the occurrence of disorganization and disappearance of the normal network among fibers.
Regarding the mechanisms by which CsA induces cardiotoxicity, it has not been documented in detail yet and still a matter of debate. In fact, it seems that CsA can cause excess free radical production during its metabolism, and/or impair antioxidant system. These free radicals could activate several protein kinases in both myocytes and fibroblasts. This mechanism has already been considered as a pathway involved in induction of cardiac fibrosis (Siwik and Colucci, 2004) . The second hypothesis, supposed an indirect action of CsA on ROS, through the decrease of cytochrome-c oxidase activity, which is an endogenous antioxidant marker (Yang and Dettbarn, 1998) . Kim et al, 2002 , documented that ROS produces cell and tissue damage after CsA administration. Nangaku et al, 2005 , reported that CsAinduced renal injury is associated with activation of the intra-renal complement system. The complement system is an important component of the immune system, but irregular or excess activation of the complement system can cause tissue damage.
The current work revealed that upon combination of CoQ 10 and CsA, better amelioration of CsA-induced histological alterations of the cardiac muscle was obvious. Cardiac myocytes expressed a morphological pattern similar to that of the controls except for little amount of disorganization of myocardial fibers, mitochondria and few sarcoplasmic vacuoles between myofibrils.
Since the role of free radicals in CsA cardiotoxicity is widely accepted. Therapeutic strategies are aimed for limiting free radical mediated injury. So, CoQ 10 was tried in the current study. The reduced form of CoQ 10 is the only endogenously synthesized lipophilic antioxidant. CoQ 10 act as antioxidant directly by protecting biological membranes against oxidants, and can also inhibit the peroxidation of lipoprotein lipids present in the blood (Nishimura et al, 2009 ). The hydrophobic character of CsA may suggest that the most potent protector from its harmful effect on lipid membranes can be the main hydrophobic antioxidant, vitamin E and CoQ 10 (Sawicka et al, 2006) . Sawicka et al, 2006 , reported that CoQ 10 appears to be more protective (given before CsA) than a reparative agent in decreasing the lipid peroxidation enhanced by CsA. Ankola et al, 2010 , described the first trial to design nano-scale systems for simultaneous encapsulation of CsA and CoQ 10 . They stated that the combination therapy of both CsA and CoQ 10 in one capsule will soon become a reality.
In parallel with our results, Ebru et al, 2008 , observed that pretreatment with Nigella Sativa oil reduced the subsequent CsA-induced injury in rat's heart, demonstrated by normalized cardiac histopathology, decrease lipid peroxidation and improvement in the antioxidant enzyme status.
From the above mentioned results it could be concluded that: CoQ 10 partially alleviates the CsAinduced cardiotoxicity in the form of decreasing the elevated systolic, diastolic blood pressure, and heart rate. Morever, CoQ 10 reduced the occurrence of major histological changes in the cardiac muscles as evidenced by light and electron microscope. On the light of the results of this study, the use of CoQ 10 as a cardioprotective against CsA-induced cardiotoxicity could be recommended.
